InvestorsHub Logo
Followers 25
Posts 2322
Boards Moderated 0
Alias Born 03/18/2013

Re: dmiller post# 193972

Wednesday, 05/29/2019 12:39:52 PM

Wednesday, May 29, 2019 12:39:52 PM

Post# of 430335
Post 193954; whythestocks;

https://marketwirenews.com/news-releases/u-s-fda-grants-priority-review-for-vascepa-xae-icosapent-ethyl-supplemental-new-drug-application-seeking-cardiovascular-risk-reduction-indication-8260912.html

“We expect earlier approval of an expanded indication for Vascepa to lead to faster improvements in care for millions of patients with residual cardiovascular risk after statin therapy,” said John F. Thero, president and chief executive officer of Amarin. “

What do you think it means?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News